Hospital Teaching Status and Outcomes in Type B Aortic Dissection: Analysis of More Than 40,000 Patients

J Cardiothorac Vasc AnesthPublished Retrospective cross-sectional study

Main finding · In-hospital mortalityResult — go to the resultOdds ratio 0.943 95% CI 0.841–1.057

Authors' conclusion

Hospital teaching status alone was not associated with in-hospital mortality or 30-day readmission in TBAD patients.

Study context

Population
Patients with type B aortic dissection (TBAD), US hospitals, 2016–2020
Participants
44,981 patients · 4,676 matched pairs
Exposure
Teaching vs nonteaching hospitals
  • Nonteaching (NT)n = 5,421reference
  • Tn = 39,470
Outcome
In-hospital mortality
Methodological detailsNational Readmissions Database, propensity score matched (1:1), multivariable regression
  • National Readmissions Database
  • Propensity score matched (1:1)
  • Multivariable regression

Main finding

As reported in the abstract

Odds ratio

0.943

95% CI 0.841–1.057

P = 0.31

By group

T vs NT
OR 0.943 (95% CI 0.841–1.057); P = 0.31

Observational data: associations, not effects.

Further findings

30-day readmission · 30 days — NT vs T · propensity-matched

P = 0.12

OutcomeOR (95% CI)P value
30-day readmission · 30 daysT vs NT · multivariable regression0.965 (0.88–1.058)P = 0.44

In-hospital mortality with thoracic endovascular aortic repair (TEVAR) at teaching hospitals

OR (95% CI)P value
TEVAR1.898 (1.596–2.257)P < 0.01

30-day readmission by hospital volume at teaching hospitals

OR (95% CI)P value
Volume quartile 31.488 (1.106–2.002)P < 0.01
Volume quartile 41.684 (1.256–2.257)P < 0.01

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Hospital Teaching Status and Outcomes in Type B Aortic Dissection: Analysis of More Than 40,000 Patients. J Cardiothorac Vasc Anesth. Published 28 October 2024. doi:10.1053/j.jvca.2024.10.039

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.